Caveat Emptor: Let Our Acclaim of the Apotheosis of PRRT Not Blind Us to the Error of Prometheus

被引：7
作者：
Bodei, Lisa [1 ]
Herrmann, Ken [2 ,3 ]
Baum, Richard P. [4 ]
Kidd, Mark [5 ]
Malczewska, Anna [6 ]
Modlin, Irvin M. [7 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[3] Univ Klinikum Essen, Klin Nukl Med, Essen, Germany
[4] Zentralklin Bad Berka, Theranost Ctr Mol Radiotherapy & Imaging, Bad Berka, Germany
[5] Wren Labs, Branford, CT USA
[6] Med Univ Silesia, Dept Endocrinol & Neuroendocrine Tumors, Katowice, Poland
[7] Yale Sch Med, Dept Surg, New Haven, CT USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷 / 01期
关键词：
NEUROENDOCRINE; THERAPY;
D O I：
10.2967/jnumed.118.219386
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：7 / 8
页数：2
相关论文
共 8 条
  • [1] Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors
    Bodei, L.
    Kidd, M.
    Modlin, I. M.
    Severi, S.
    Drozdov, I.
    Nicolini, S.
    Kwekkeboom, D. J.
    Krenning, E. P.
    Baum, R. P.
    Paganelli, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (05) : 839 - 851
  • [2] PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy
    Bodei, Lisa
    Kidd, Mark S.
    Singh, Aviral
    van der Zwan, Wouter A.
    Severi, Stefano
    Drozdov, Ignat A.
    Cwikla, Jaroslaw
    Baum, Richard P.
    Kwekkeboom, Dik J.
    Paganelli, Giovanni
    Krenning, Eric P.
    Modlin, Irvin M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (07) : 1155 - 1169
  • [3] Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
    Kwekkeboom, Dik J.
    Kam, Boen L.
    van Essen, Martijn
    Teunissen, Jaap J. M.
    van Eijck, Casper H. J.
    Valkema, Roelf
    de Jong, Marion
    de Herder, Wouter W.
    Krenning, Eric P.
    [J]. ENDOCRINE-RELATED CANCER, 2010, 17 (01) : R53 - R73
  • [4] Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE
    Sansovini, Maddalena
    Severi, Stefano
    Ianniello, Annarita
    Nicolini, Silvia
    Fantini, Lorenzo
    Mezzenga, Emilio
    Ferroni, Fabio
    Scarpi, Emanuela
    Monti, Manuela
    Bongiovanni, Alberto
    Cingarlini, Sara
    Grana, Chiara Maria
    Bodei, Lisa
    Paganelli, Giovanni
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (03) : 490 - 499
  • [5] Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
    Sparano, J. A.
    Gray, R. J.
    Makower, D. F.
    Pritchard, K. I.
    Albain, K. S.
    Hayes, D. F.
    Geyer, C. E., Jr.
    Dees, E. C.
    Goetz, M. P.
    Olson, J. A., Jr.
    Lively, T.
    Badve, S. S.
    Saphner, T. J.
    Wagner, L. I.
    Whelan, T. J.
    Ellis, M. J.
    Paik, S.
    Wood, W. C.
    Ravdin, P. M.
    Keane, M. M.
    Moreno, H. L. Gomez
    Reddy, P. S.
    Goggins, T. F.
    Mayer, I. A.
    Brufsky, A. M.
    Toppmeyer, D. L.
    Kaklamani, V. G.
    Berenberg, J. L.
    Abrams, J.
    Sledge, G. W., Jr.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (02) : 111 - 121
  • [6] Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
    Strosberg, J.
    El-Haddad, G.
    Wolin, E.
    Hendifar, A.
    Yao, J.
    Chasen, B.
    Mittra, E.
    Kunz, P. L.
    Kulke, M. H.
    Jacene, H.
    Bushnell, D.
    O'Dorisio, T. M.
    Baum, R. P.
    Kulkarni, H. R.
    Caplin, M.
    Lebtahi, R.
    Hobday, T.
    Delpassand, E.
    Van Cutsem, E.
    Benson, A.
    Srirajaskanthan, R.
    Pavel, M.
    Mora, J.
    Berlin, J.
    Grande, E.
    Reed, N.
    Seregni, E.
    Oberg, K.
    Sierra, M. Lopera
    Santoro, P.
    Thevenet, T.
    Erion, J. L.
    Ruszniewski, P.
    Kwekkeboom, D.
    Krenning, E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (02) : 125 - 135
  • [7] First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
    Ulaner, Gary A.
    Lyashchenko, Serge K.
    Riedl, Christopher
    Ruan, Shutian
    Zanzonico, Pat B.
    Lake, Diana
    Jhaveri, Komal
    Zeglis, Brian
    Lewis, Jason S.
    O'Donoghue, Joseph A.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (06) : 900 - 906
  • [8] Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis
    Ward, S.
    Scope, A.
    Rafia, R.
    Pandor, A.
    Harnan, S.
    Evans, P.
    Wyld, L.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2013, 17 (44) : 1 - +
1